Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy
Foulkes SJ, Howden EJ, Bigaran A et Al.
Med Sci Sports Exerc. 2019 Aug;51(8):1573-1581. doi: 10.1249/MSS.0000000000001970.
CARDIONCOLOGY.ORG ABSTRACT:
Anthracycline chemotherapy (AC) is associated with acute reductions in cardiopulmonary fitness (V ̇O2peak).
This article found changes in V ̇O2peak and cardiac function in female breast cancer patients at 12 months post-AC completion and question whether these changes can account for long-term heart failure risk.
© All rights reserved